Provexis plc is a life sciences-driven company that discovers, develops and licenses technologies for the global functional food, medical food and dietary supplement sectors. Its technologies include Fruitflow, NSP#3G, isothiocyanate and blood glucose. Fruitflow is a heart-health technology. Fruitflow is a tomato extract, which inhibits platelet aggregation, a known cause of heart attack, stroke and venous thrombosis. NSP#3G is a technology for Crohn�s disease. On June 1, 2010, it entered into an alliance with DSM Nutritional Products (DSM) to develop Fruitflow. It has 75% interest in a joint venture with the University of Liverpool, which owns the NSP#3G plantain extract for the treatment of inflammatory bowel disease. On June 17, 2011, the Company acquired SiS (Science in Sport) Limited (SiS), which manufactures and sells sports nutrition products. In May 2012, it opened a new manufacturing facility in Nelson, Lancashire for the Company's SiS sports nutrition business.